Skin and Soft Tissue Infection (Staphylococcus aureus)
Overview
Plain-Language Overview
Skin and Soft Tissue Infection (Staphylococcus aureus) is a common infection that affects the skin and underlying tissues. It usually causes redness, swelling, pain, and sometimes pus-filled bumps or abscesses. This infection can occur anywhere on the body but often affects areas with cuts, scrapes, or insect bites. The main concern is that the infection can spread deeper into the body or cause systemic illness if untreated. The bacteria responsible, Staphylococcus aureus, can sometimes be resistant to antibiotics, making treatment more challenging. Early recognition of symptoms is important to prevent complications. Overall, it impacts the body's ability to protect itself from infection and maintain healthy skin.
Clinical Definition
Skin and Soft Tissue Infection (Staphylococcus aureus) is defined as an infection involving the epidermis, dermis, and subcutaneous tissues caused primarily by the gram-positive cocci Staphylococcus aureus. The pathogenesis involves bacterial invasion through breaches in the skin barrier, followed by local inflammation and immune response. Common clinical manifestations include cellulitis, abscess formation, folliculitis, and impetigo. The infection is significant due to its potential for rapid progression, local tissue destruction, and systemic spread leading to bacteremia or sepsis. Methicillin-resistant S. aureus (MRSA) strains pose a major therapeutic challenge. Diagnosis relies on clinical presentation supported by microbiological culture. Understanding the virulence factors such as protein A, coagulase, and toxins is essential for grasping the disease mechanism.
Inciting Event
Minor skin trauma such as cuts, abrasions, or insect bites initiates infection.
Nasal colonization with S. aureus serves as a reservoir for autoinoculation.
Surgical wounds or invasive procedures breach skin defenses.
Contact with contaminated fomites or infected individuals transmits bacteria.
Chronic skin conditions like atopic dermatitis disrupt barrier and promote colonization.
Latency Period
Symptoms typically develop within 1 to 5 days after bacterial inoculation.
Rapid progression can occur in toxin-mediated syndromes like toxic shock.
Localized abscesses may evolve over several days before clinical recognition.
Delayed presentation is common in deep soft tissue infections such as cellulitis.
Recurrent infections may occur weeks to months after initial episode due to persistent colonization.
Diagnostic Delay
Early symptoms mimic other skin conditions such as insect bites or allergic reactions.
Lack of fever or systemic signs in initial stages may delay suspicion.
Misattribution to non-infectious causes like eczema or contact dermatitis.
Failure to recognize abscess formation requiring drainage delays definitive treatment.
Inadequate history of trauma or exposure may obscure diagnosis.
Clinical Presentation
Signs & Symptoms
Localized pain, swelling, and erythema at the infection site
Fever and systemic symptoms in more severe or invasive infections
Pustules, furuncles, or carbuncles representing different abscess forms
Itching or burning sensation preceding lesion development
Tender regional lymph nodes may accompany the infection
History of Present Illness
Rapid onset of localized erythema, warmth, and swelling at the infection site.
Pain and tenderness increase over hours to days, often with purulent discharge.
Fever and malaise may accompany extensive or deep infections.
Progression from folliculitis to furuncles or carbuncles is common.
Recurrent episodes at the same site suggest persistent colonization or inadequate treatment.
Past Medical History
Previous skin infections with S. aureus increase risk of recurrence.
Chronic illnesses such as diabetes or peripheral vascular disease impair healing.
History of eczema or other chronic skin conditions disrupts barrier function.
Recent hospitalization or surgery increases exposure to resistant strains.
Use of immunosuppressive medications predisposes to severe infections.
Family History
Family members colonized with S. aureus increase transmission risk.
Genetic predisposition to skin barrier defects may contribute to recurrent infections.
No specific inherited syndromes are directly linked to S. aureus skin infections.
Familial clustering of atopic dermatitis can indirectly increase susceptibility.
Shared environmental exposures within families facilitate bacterial spread.
Physical Exam Findings
Erythema and warmth localized to the affected skin area
Tenderness and induration over the site of infection
Presence of fluctuant abscess indicating localized pus collection
Purulent drainage or crusting if the lesion is ruptured
Regional lymphadenopathy may be present near the infection site
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established primarily through clinical examination revealing localized erythema, warmth, swelling, and tenderness consistent with infection. Identification of purulent material via abscess drainage or swab allows for Gram stain and culture, confirming Staphylococcus aureus as the causative agent. Blood cultures may be indicated if systemic infection is suspected. Imaging such as ultrasound can help detect abscess formation. The presence of methicillin resistance is determined by antibiotic susceptibility testing to guide therapy.
Pathophysiology
Key Mechanisms
Toxin production by Staphylococcus aureus including exfoliative toxins causing skin damage.
Panton-Valentine leukocidin (PVL) toxin induces neutrophil lysis and tissue necrosis.
Biofilm formation on skin and soft tissues protects bacteria from immune clearance and antibiotics.
Host immune response with neutrophil infiltration leads to inflammation and abscess formation.
Enzymatic tissue destruction by hyaluronidase and proteases facilitates bacterial spread.
| Involvement | Details |
|---|---|
| Organs | Skin is the primary organ affected in Staphylococcus aureus skin and soft tissue infections presenting with erythema, warmth, and swelling. |
Lymph nodes may become enlarged and tender due to regional immune activation and drainage of infected material. | |
Kidneys can be affected in severe systemic infections causing complications like acute glomerulonephritis. | |
| Tissues | Epidermis serves as the initial barrier breached by Staphylococcus aureus leading to localized infection. |
Dermis contains blood vessels and immune cells that participate in the inflammatory response to infection. | |
Subcutaneous tissue may be involved in deeper infections such as abscess formation. | |
| Cells | Neutrophils are the primary immune cells that phagocytose and kill Staphylococcus aureus during skin infections. |
Macrophages contribute to bacterial clearance and secrete cytokines that mediate inflammation in infected tissues. | |
Keratinocytes produce antimicrobial peptides and cytokines that help contain the infection in the skin. | |
| Chemical Mediators | Interleukin-1 (IL-1) promotes local inflammation and recruits immune cells to the site of infection. |
Tumor necrosis factor-alpha (TNF-α) enhances vascular permeability and activates immune responses against Staphylococcus aureus. | |
C-reactive protein (CRP) is an acute phase reactant elevated in systemic inflammation during skin and soft tissue infections. |
Treatments
Pharmacological Treatments
Nafcillin or Oxacillin
- Mechanism:
Beta-lactam antibiotics that inhibit bacterial cell wall synthesis by binding penicillin-binding proteins.
- Side effects:
Allergic reactions
Interstitial nephritis
Elevated liver enzymes
- Clinical role:
First-line
Vancomycin
- Mechanism:
Glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding D-Ala-D-Ala terminus of cell wall precursors.
- Side effects:
Nephrotoxicity
Ototoxicity
Red man syndrome
- Clinical role:
First-line for MRSA
Clindamycin
- Mechanism:
Inhibits bacterial protein synthesis by binding the 50S ribosomal subunit.
- Side effects:
Clostridioides difficile colitis
Rash
Diarrhea
- Clinical role:
Alternative for mild to moderate infections
Linezolid
- Mechanism:
Oxazolidinone that inhibits bacterial protein synthesis by binding the 23S rRNA of the 50S subunit.
- Side effects:
Thrombocytopenia
Peripheral neuropathy
Serotonin syndrome
- Clinical role:
Second-line for resistant infections
Non-pharmacological Treatments
Incision and drainage of abscesses to remove purulent material and reduce bacterial load.
Wound care with regular cleaning and dressing changes to promote healing and prevent secondary infection.
Elevation and immobilization of affected limb to reduce swelling and pain.
Prevention
Pharmacological Prevention
Nasal mupirocin ointment to eradicate S. aureus colonization in carriers
Chlorhexidine washes to reduce skin colonization in high-risk patients
Prophylactic antibiotics in recurrent or severe cases under specialist guidance
Non-pharmacological Prevention
Proper wound care including cleaning and dressing to prevent infection
Hand hygiene to reduce transmission of Staphylococcus aureus
Avoiding sharing personal items like towels or razors
Maintaining skin hydration and integrity to prevent breaks in the barrier
Screening and decolonization protocols in healthcare settings to reduce outbreaks
Outcome & Complications
Complications
Sepsis from hematogenous spread of Staphylococcus aureus
Necrotizing fasciitis as a rapidly progressive soft tissue infection
Osteomyelitis if infection spreads to underlying bone
Endocarditis in cases of bacteremia with cardiac valve involvement
Post-infectious glomerulonephritis as an immune-mediated complication
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Skin and Soft Tissue Infection (Staphylococcus aureus) versus Cellulitis (Streptococcus pyogenes)
Skin and Soft Tissue Infection (Staphylococcus aureus) | Cellulitis (Streptococcus pyogenes) |
|---|---|
Usually caused by Staphylococcus aureus | Usually caused by Streptococcus pyogenes |
Localized abscess or purulent collection in skin or soft tissue | Diffuse spreading infection of dermis and subcutaneous tissue without abscess formation |
Often requires incision and drainage plus antibiotics targeting MRSA | Responds well to beta-lactam antibiotics without need for drainage |
Skin and Soft Tissue Infection (Staphylococcus aureus) versus Erysipelas
Skin and Soft Tissue Infection (Staphylococcus aureus) | Erysipelas |
|---|---|
Caused by Staphylococcus aureus | Caused by Streptococcus pyogenes |
Involves deeper dermis and subcutaneous tissue with less distinct borders | Involves upper dermis and superficial lymphatics with sharply demarcated raised borders |
Tender, fluctuant abscess or pustule with surrounding erythema | Bright red, raised, sharply demarcated plaques often on face or legs |
Skin and Soft Tissue Infection (Staphylococcus aureus) versus Necrotizing Fasciitis
Skin and Soft Tissue Infection (Staphylococcus aureus) | Necrotizing Fasciitis |
|---|---|
Slower progression with localized pain and swelling | Rapidly progressive with severe pain out of proportion to exam |
Infection localized to skin and subcutaneous tissue without fascial involvement | Infection spreads along fascial planes causing tissue necrosis |
Often managed with incision and drainage plus targeted antibiotics | Requires emergent surgical debridement plus broad-spectrum antibiotics |
Skin and Soft Tissue Infection (Staphylococcus aureus) versus Abscess due to Candida albicans
Skin and Soft Tissue Infection (Staphylococcus aureus) | Abscess due to Candida albicans |
|---|---|
Bacterial infection caused by Staphylococcus aureus | Fungal infection caused by Candida albicans |
Occurs in immunocompetent and immunocompromised hosts | More common in immunocompromised patients |
Positive bacterial culture showing gram-positive cocci in clusters | Positive fungal culture or KOH prep showing yeast |
Skin and Soft Tissue Infection (Staphylococcus aureus) versus Herpes Simplex Virus (HSV) Infection
Skin and Soft Tissue Infection (Staphylococcus aureus) | Herpes Simplex Virus (HSV) Infection |
|---|---|
Bacterial infection caused by Staphylococcus aureus | Viral infection caused by HSV-1 or HSV-2 |
Tender, fluctuant abscess or pustule with purulent drainage | Painful grouped vesicles on erythematous base |
Positive bacterial culture with gram-positive cocci | Positive PCR or Tzanck smear showing multinucleated giant cells |